Histiocytic neoplasms in the era of personalized genomic medicine Review uri icon

Overview

MeSH Major

  • Histiocytoma

abstract

  • Genomic analyses over the last 6 years have identified targetable kinase alterations in BRAF V600E-wildtype histiocytic neoplasms. However, despite this progress, the molecular pathogenesis and therapeutic responsiveness of non-BRAF V600E kinase alterations are still poorly defined in these disorders.

publication date

  • July 2016

Research

keywords

  • Review

Identity

Language

  • eng

PubMed Central ID

  • PMC5112586

Digital Object Identifier (DOI)

  • 10.1097/MOH.0000000000000256

PubMed ID

  • 27101528

Additional Document Info

start page

  • 416

end page

  • 25

volume

  • 23

number

  • 4